These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16839510)

  • 1. Wegener's granulomatosis: is biologic therapy useful?
    Sarraf P; Kay J; Friday RP; Reginato AM
    Curr Rheumatol Rep; 2006 Aug; 8(4):303-11. PubMed ID: 16839510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of the Wegener's Granulomatosis Etanercept Trial (WGET).
    WGET Research Group
    Control Clin Trials; 2002 Aug; 23(4):450-68. PubMed ID: 12161090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the therapy of Wegener's granulomatosis.
    Hellmich B; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
    Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab as an effective and probably safe treatment for granulomatosis with polyangiitis (Wegener's Granulomatosis).
    Tavakolpour S; Alesaeidi S
    Int Immunopharmacol; 2019 May; 70():67-68. PubMed ID: 30785092
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
    Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
    Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Wegener's granulomatosis.
    Regan MJ; Hellmann DB; Stone JH
    Rheum Dis Clin North Am; 2001 Nov; 27(4):863-86, viii. PubMed ID: 11723769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
    Azar L; Springer J; Langford CA; Hoffman GS
    Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
    Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
    Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Wegener's granulomatosis].
    Riccieri V; Valesini G
    Reumatismo; 2004; 56(2):69-76. PubMed ID: 15309213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.
    Bachmeyer C; Cadranel JF; Demontis R
    Nephrol Dial Transplant; 2005 Jun; 20(6):1274. PubMed ID: 15840659
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wegener's granulomatosis.
    Hoffman GS
    Curr Opin Rheumatol; 1993 Jan; 5(1):11-7. PubMed ID: 8435284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital presentation of systemic vasculitis: a diagnostic and management challenge.
    Singh M; Singh U; Zadeng Z
    Nepal J Ophthalmol; 2015; 7(1):65-8. PubMed ID: 26695609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in refractory Wegener's granulomatosis: Favorable or not?
    Aries PM; Lamprecht P; Gross WL
    Am J Respir Crit Care Med; 2006 Apr; 173(7):815-6; author reply 816. PubMed ID: 16556703
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
    Tektonidou MG; Skopouli FN
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S103. PubMed ID: 16859607
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological therapy for Wegener's granulomatosis.
    White ES; Lynch JP
    Drugs; 2006; 66(9):1209-28. PubMed ID: 16827598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.